Treatment type: Immunotherapies
-
The elusive protein that’s crucial for male and female sexual health
A naturally occurring anti-viral protein first discovered at Hudson Institute is proving essential to human sexual health, even playing a part in protecting against cancer, with new proof that it’s an Important factor for men as well as women.… Read more
-
Hudson Lab Secures Three Grants to Battle Childhood Cancers
In a significant advancement for pediatric cancer research, Dr Pouya Faridi—the head of the Translational Antigen Discovery Laboratory and Childhood Cancer Immunotherapy Program Lead—announced that his lab has been awarded three grants from Tour de Cure Australia.… Read more
-
Uncovering the cellular secrets of RNA editing
Professor Carl Walkley heads the RNA Biology and Innate Immune Sensing Research Group at Hudson Institute of Medical Research and their latest research, published in Science Immunology, sheds new light on these crucial processes.… Read more
-
New CRE for Nucleic Acid Sensing boosts RNA therapeutics
The frontline of defences against viruses and other pathogens will be fortified by the creation of a new Centre of Research Excellence for Nucleic Acid Sensing, located at Hudson Institute. … Read more
-
MRFF funding advances Hudson Institute RNA therapies
Hudson Institute of Medical Research has been recognised as a leader in RNA based medicine, with new federal government funding set to accelerate the search for new and better treatments.… Read more
-
2024 expert flu season guide
Hudson Institute’s resident flu guru, Associate Professor Michelle Tate, answers all your questions heading into this flu season.… Read more
-
Hudson success in 2024 NHMRC Investigator grants
Hudson Institute Group Heads, Professor Claudia Nold and Associate Professor Flora Wong were each awarded grants of more than $2 million over the next five years, enabling them to commit long-term to these exciting research projects.… Read more
-
New arrivals boost Hudson’s inflammation research leadership
Hudson Institute’s reputation as a leader in inflammation research has been boosted by the appointment of two specialists in the field.… Read more
-
Funding boosts search for children’s brain cancer cure
A deadly form of children’s brain cancer that’s immune to chemotherapy is the target of new research at Hudson Institute, looking at the epigenome and immuno-therapies for answers.… Read more
-
Better treatments sooner: Hudson unveils RNAte Platform
Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.… Read more